TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LWAY

Lifeway Foods Inc

Consumer Defensive · Packaged Foods · listed since 1987

23.80$ -2.6% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

The business fundamentally works: demand is real, the brand leads its category, the balance sheet carries the company, and there is no evidence of a threat to its substance. What is open is one material operating question — does gross margin return to its earlier level after the drop to 19.5 percent, or was that earlier level the exception? Until that is settled, what stands here is a company that has added a third to its revenue since 2023 and earns less on it, that funds its plant expansion with debt, and whose takeover and ownership fight has cost 10.7 million dollars in legal and professional fees over two years. Anyone waiting should check three lines in the next filing: the gross margin, the remaining headroom on the credit facility and the Waukesha cost estimate. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Lifeway Foods demonstrably sells more kefir every year — 27 consecutive quarters, four record years in a row. What that turns into as profit is the open question: operating income in 2025 was below 2023, gross margin collapsed to 19.5 percent in the second quarter of 2026, and the Waukesha expansion is being funded with bank debt while the revolving facility is 88 percent drawn. On top of that sits an ownership structure in which the chief executive's brother and mother together hold more shares than she does, and in which the strategic anchor shareholder exited in May 2026 at a clear discount to its own earlier bid. The decisive numbers in the next filings are the gross margin, the remaining headroom on the credit facility and the Waukesha cost estimate. Not investment advice.

Demand & market position

27 consecutive quarters of year-over-year net sales growth and four record years in a row (141.6 million dollars in 2022 to 212.5 million in 2025), described by the company as consistently volume-led. Lifeway describes itself in its annual report as the largest kefir producer in the United States and makes 95 percent of its net sales in its own plants.

Earning power

Operating income was 16.2 million dollars in 2025, below the 17.0 million of 2023 — on a third more revenue. The operating margin fell from 10.6 to 7.5 percent. In the second quarter of 2026, 66.9 million dollars of net sales left 0.1 million of net income.

Margin & raw-material exposure

Gross margin fell from 28.6 to 19.5 percent in the second quarter of 2026; the company names milk prices as the main cause. The same factor was cited on the three preceding calls as the reason for margin improvements — the margin follows the commodity more closely than it follows execution.

Cash position & cash flow

In the first half of 2026, 4.0 million dollars of operating cash flow met 19.5 million of capital spending; cash fell to 7.1 million and 22.0 million of the 25.0 million revolving facility was drawn. An equipment financing facility of up to 22.0 million stands ready; the bank covenants were met at 2026-06-30.

Balance-sheet substance

Equity of 84.6 million dollars on total assets of 132.4 million (2026-06-30), no going-concern language, no impairment of the 11.7 million goodwill balance, and interest cover of roughly 24 times in the first half of 2026.

Ownership & governance

The chief executive's brother and mother together hold 24.90 percent against her 17.52 percent (2026-04-30); a campaign against the board by her brother in 2025, roughly a quarter of votes against the board at the 2026 annual meeting, 10.7 million dollars of legal and advisory fees over two years, and strategic holder Danone exited at 19.50 dollars per share in May 2026.

Concentration

85 percent of 2025 net sales came from drinkable kefir and 24 percent from two retail customers (first half of 2026: 25 percent). In U.S. food retail that is neither unusual nor existential, but it limits the ability to pass higher input costs on.

Worth Noting

The source base is the Form 10-Q for the quarter ended 2026-06-30 (filed 2026-08-13), the Forms 10-K for 2023 through 2025, the Forms 8-K dated 2026-06-03, 2026-06-05, 2026-06-18, 2026-07-07 and 2026-08-13, the prospectus supplement 424B7 dated 2026-05-14 and the proxy statement DEF 14A dated 2026-04-30.

The 2025 net income of 13.9 million dollars includes a one-off gain of 3.4 million dollars on the sale of the Simple Mills investment; the reported 54 percent increase over 2024 is considerably smaller without that item.

Only the prepared remarks are available for the three earnings presentations analysed (2025-11-12, 2026-03-17, 2026-05-14); none of the transcripts contains a question-and-answer section. No transcript was available for the second quarter of 2026 at the time of writing.

The ownership figures come from two dates: the annual report gives rounded values as of 2025-12-31 (roughly 18, 20, 6, 23 and 9 percent), the proxy statement exact values as of 2026-04-30. Danone sold its entire block on 2026-05-14.

Analyst coverage is very thin; a price target from that source would not be a meaningful sample and is therefore not used as an anchor.

Stock Watch

This analysis is as of August 29, 2026. Stock Watch will tell you what's changed at LWAY since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 17.80 $ to 33.80 $ · Last price: 23.80 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.4$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 15m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 43.0%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.4

Performance

Perf. 1M ?Price performance over the last month. 24.60%
Perf. 3M ?Price performance over the last 3 months. 63.50%
Perf. 6M ?Price performance over the last 6 months. 24.70%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 18.10%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -11.3%
Perf. 1Y ?Price performance over the last 12 months. -29.66%
Perf. 3Y ?Price performance over the last 3 years. 98.25%
Perf. 5Y ?Price performance over the last 5 years. 303.22%
Perf. 10Y ?Price performance over the last 10 years. 49.06%
Perf. Since Inception ?Price performance since the first available trading day (12/29/1988) — with a complete history, that is since the IPO. 4,178.78%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 27.00$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 28.10$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 24.80$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 29.7
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 60.2%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 43.3%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 29.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 3.5
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 1.5
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 19.2
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 27.2%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 4.5%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 18.2%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 8.5%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 11.32
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 5 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 36.70%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 30.40%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 13.74%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 13.32%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 300.00%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 3
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 74
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 71
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (58 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Packaged Foods

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Lifeway Foods Inc LWAY 0.4 19.2 27.2 13.7 -29.7
JBS N.V. JBS 39.9 11.7 6.2 11.8 2.5 13.0 -16.1
Kraft Heinz Co KHC 29.1 13.1 33.5 20.7 -3.5 2.7
General Mills Inc GIS 19.9 9.2 21.6 33.7 19.2 -1.9 -20.8
McCormick & Company Incorporated MKC-V 13.8 8.6 13.4 38.9 17.4 1.7 -18.7
McCormick & Company Incorporated MKC 13.5 8.9 13.1 38.9 17.4 1.7 -23.2
The J. M. Smucker Company SJM 12.8 14.8 38.0 18.5 3.7 22.5
Hormel Foods Corporation HRL 11.6 28.1 15.5 15.7 11.1 1.6 -12.2
Darling Ingredients Inc DAR 10.7 48.5 9.6 26.3 8.1 7.4 100.8
Median of companies shown 13.5 10.4 13.4 33.5 17.4 1.7 -16.1

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 124 $M 2016 · Operating income: 6 $M 2016 · Net income: 3 $M 2017 · Revenue: 119 $M 2017 · Operating income: -1 $M 2017 · Net income: 0 $M 2018 · Revenue: 103 $M 2018 · Operating income: -3 $M 2018 · Net income: -3 $M 2019 · Revenue: 94 $M 2019 · Operating income: -2 $M 2019 · Net income: 0 $M 2020 · Revenue: 102 $M 2020 · Operating income: 5 $M 2020 · Net income: 3 $M 2021 · Revenue: 119 $M 2021 · Operating income: 6 $M 2021 · Net income: 3 $M 2022 · Revenue: 142 $M 2022 · Operating income: 2 $M 2022 · Net income: 1 $M 2023 · Revenue: 160 $M 2023 · Operating income: 17 $M 2023 · Net income: 11 $M 2024 · Revenue: 187 $M 2024 · Operating income: 14 $M 2024 · Net income: 9 $M 2025 · Revenue: 213 $M 2025 · Operating income: 16 $M 2025 · Net income: 14 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 124 6 3 0.22 5 48 66
2017 119 -1 0 -0.02 4 47 65
2018 103 -3 -3 -0.19 2 42 57
2019 94 -2 0 0.03 4 43 59
2020 102 5 3 0.21 6 47 62
2021 119 6 3 0.21 6 49 71
2022 142 2 1 0.06 4 48 69
2023 160 17 11 0.75 17 60 83
2024 187 14 9 0.59 13 72 91
2025 213 16 14 0.89 11 86 106

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 46.9 $M Q4 2025: Q1 · 46.1 $M Q1 2025: Q2 · 53.9 $M Q2 2025: Q3 · 57.1 $M Q3 2025: Q4 · 55.4 $M Q4 2026: Q1 · 63.0 $M Q1 2026: Q2 · 66.9 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.01 -104.00 47 11.50 -0.30 -3 -4
2025: Q1 0.23 45.90 46 3.30 7.70 0 -2
2025: Q2 0.28 12.30 54 9.70 7.90 4 2
2025: Q3 0.23 18.60 57 24.00 6.20 7 2
2025: Q4 0.17 55 18.00 4.60 0 -17
2026: Q1 0.31 32.00 63 36.70 7.40 4 -7
2026: Q2 0.01 -96.40 67 24.10 0.10 0 -9

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 10 of our scanner strategies — each hit links to the scanner.

Backtested Scanners

Growth

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 1
Price Target (average) 33.00$
Distance to price 38.7% The price target sits 38.7% above the current price.

Distribution of Recommendations

Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 0.50 0.50 – 0.50 263 1
12/31/2027 1.35 1.35 – 1.35 298 170.0% 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Lifeway Foods stellt Kefir und Frischkäse her; in den ausgewerteten Filings gibt es keine KI-Umsatzquelle und keinen belegten operativen KI-Einsatz. Der einzige KI-Bezug ist ein allgemein gehaltener Risikohinweis im Geschäftsbericht 2025 ohne konkreten Bezug zum eigenen Geschäftsmodell.

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-Q 2026-08-13 · 10-Q 2026-05-14 · 10-Q 2025-11-12 · 10-Q 2025-08-12 · 10-K 2026-03-17 · 10-K 2025-03-14

Rated on August 29, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

7 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years 14.5%
  • More than 10% revenue growth is expected for the coming year 13.3%
  • Share count grows by less than 3% a year -0.4%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 6.0%
  • Gross margin at 40% or higher and without meaningful erosion 27.4%
  • Goodwill from acquisitions does not grow faster than revenue 11.1%
  • Net debt below twice EBITDA 5 m net cash
  • Operating cash flow covers the profits of the last three years 7 m
  • Return on capital at 15% or higher, or up versus two years ago 18.2%
  • Insiders hold at least 10% or are net buyers 39.4%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

8/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 6.2%
  • Exp. sales growth 3Y > 5% 18.5%
  • EBIT growth 10Y > 5% 11.5%
  • Exp. EBIT growth 3Y > 5% 23.0%
  • Net debt < 4x EBIT -0.3x
  • EBIT positive, 10Y straight 7
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% 20.3%
  • ROCE > 15% 18.2%
  • Expected return > 10% 17.6%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 31, 2026 McWhorter Dorri Director Other 1,550 0.00
Aug 19, 2026 Smolyansky Julie CEO, President and Secretary Buy 2,000 25.26 50,520
Aug 17, 2026 Divisadero Street Capital Management, LP 10% Owner Buy 35,952 24.78 890,923
Aug 14, 2026 Divisadero Street Capital Management, LP 10% Owner Buy 15,000 24.69 370,352
Aug 14, 2026 Smolyansky Edward 10% Owner Sell 31 26.50 822
Aug 14, 2026 Smolyansky Edward 10% Owner Sell 45,038 25.82 1,162,881
Aug 14, 2026 Smolyansky Edward 10% Owner Sell 29,931 24.89 744,983
Aug 13, 2026 Divisadero Street Capital Management, LP 10% Owner Buy 195,616 24.87 4,865,537
Aug 12, 2026 Smolyansky Edward 10% Owner Sell 35,000 28.74 1,005,900
Jul 22, 2026 Smolyansky Ludmila Member of 10% owner group Sell 40,000 29.46 1,178,400

View all insider transactions →

The company

About the Company

Lifeway Foods, Inc. produziert und vermarktet probiotikabasierte Produkte in Nordamerika.

Employees
293
Headquarters
Morton Grove, IL
Address
6431 West Oakton Street, 60053 Morton Grove, United States
Phone
847 967 1010
IPO Date
09/29/1987
ISIN
US5319141090
Stock Split
2:1 on 08/16/2006
Stock Split
2:1 on 03/09/2004

Management

Management
Name Title Birth Year
Julie Smolyansky Chairperson of the Board, CEO, President & Secretary 1975
Eric A. Hanson CFO, Chief Accounting Officer & Treasurer 1975

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/13/2026 Lifeway Foods, Inc. (LWAY): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/07/2026 Lifeway Foods, Inc. (LWAY): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?